|
|
Volumn 2, Issue 9, 2002, Pages 1037-1050
|
|
Recent advances in cyclin-dependent kinase inhibition. Purine-based derivatives as anti-cancer agents. Roles and perspectives for the future.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOSINE TRIPHOSPHATE;
ANTINEOPLASTIC AGENT;
CYCLIN DEPENDENT KINASE;
ENZYME INHIBITOR;
PURINE DERIVATIVE;
ANIMAL;
CELL CULTURE;
CELL CYCLE;
CHEMICAL STRUCTURE;
CHEMISTRY;
CLASSIFICATION;
CLINICAL TRIAL;
DRUG ANTAGONISM;
DRUG EFFECT;
HUMAN;
METABOLISM;
PROTEIN SECONDARY STRUCTURE;
REVIEW;
STRUCTURE ACTIVITY RELATION;
ADENOSINE TRIPHOSPHATE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL CYCLE;
CLINICAL TRIALS;
CYCLIN-DEPENDENT KINASES;
ENZYME INHIBITORS;
HUMANS;
MODELS, MOLECULAR;
PROTEIN STRUCTURE, SECONDARY;
PURINES;
STRUCTURE-ACTIVITY RELATIONSHIP;
TUMOR CELLS, CULTURED;
|
|
EID: 0036716567
PISSN: 15680266
EISSN: None
Source Type: Journal
DOI: 10.2174/1568026023393291 Document Type: Review |
|
Times cited : (31)
|
|
References (98)
|
